US Stock MarketDetailed Quotes
GMVDW G MEDICAL INNOVATIONS HLDGS LTD C/WTS 30/06/2025 (TO PUR COM)
- 7.0400
- 0.00000.00%
Close Aug 24 16:00 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open7.0400Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares9.000052wk High0.00P/B0Float Cap0.640052wk Low--Dividend TTM0Shs Float9.0000Historical High--Div YieldTTM0.00%Amplitude0.0036Historical Low--Avg Price1Lot Size
G MEDICAL INNOVATIONS HLDGS LTD C/WTS 30/06/2025 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | (Q3)Sep 30, 2019 | (Q2)Jun 30, 2019 | (Q1)Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -60.77%-18.48M | -147.34%-11.49M | 26.20%-4.65M | -6.3M | ||||||
| Net income from continuing operations | -68.36%-25.07M | -17.34%-14.89M | 18.19%-12.69M | ---- | ---- | ---15.51M | ---- | ---- | ---- | ---- |
| Operating gains losses | -3,219.66%-9.79M | 44.76%-295K | -67.40%-534K | ---- | ---- | ---319K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -11.01%1.21M | -3.95%1.36M | -50.59%1.42M | ---- | ---- | --2.87M | ---- | ---- | ---- | ---- |
| Other non cash items | -132.88%-1.24M | 843.64%3.78M | 322.11%401K | ---- | ---- | --95K | ---- | ---- | ---- | ---- |
| Change In working capital | 187.41%1.84M | -302.40%-2.11M | -59.25%1.04M | ---- | ---- | --2.55M | ---- | ---- | ---- | ---- |
| -Change in receivables | 2,410.00%753K | 103.50%30K | -306.25%-858K | ---- | ---- | --416K | ---- | ---- | ---- | ---- |
| -Change in inventory | -662.64%-2.02M | -192.01%-265K | -70.52%288K | ---- | ---- | --977K | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | 266.65%3.11M | -214.56%-1.87M | 6.54%1.63M | ---- | ---- | --1.53M | ---- | ---- | ---- | ---- |
| -Change in other working capital | ---- | 72.22%-5K | 95.12%-18K | ---- | ---- | ---369K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -60.77%-18.48M | -147.34%-11.49M | 26.20%-4.65M | ---- | ---- | ---6.3M | ---- | ---- | ---- | ---- |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -12,388.24%-2.12M | 96.26%-17K | -6.06%-455K | 19.75%-126K | 100.57%1K | 91.17%-429K | 98.62%-27K | 72.55%-70K | 75.62%-157K | 88.52%-176K |
| Net PPE purchase and sale | -331.40%-2.09M | 4.54%-484K | -18.18%-507K | ---- | ---- | 81.13%-429K | ---- | ---- | ---- | ---- |
| Net other investing changes | -107.49%-35K | 798.08%467K | --52K | 19.75%-126K | 100.57%1K | ---- | 27.03%-27K | 72.55%-70K | 75.62%-157K | 88.52%-176K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -12,388.24%-2.12M | 96.26%-17K | -6.06%-455K | 19.75%-126K | 100.57%1K | 91.17%-429K | 98.62%-27K | 72.55%-70K | 75.62%-157K | 88.52%-176K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -13.92%14.86M | 220.95%17.27M | 31.09%5.38M | 47.50%2.57M | -4.17%942K | -53.63%4.1M | -90.87%449K | -72.93%793K | 56.99%1.74M | 467.03%983K |
| Net issuance payments of debt | 147.84%9.54M | 206.59%3.85M | -188.01%-3.61M | -224.53%-2.17M | -90.13%97K | -47.94%4.1M | -89.80%449K | -72.93%793K | 56.99%1.74M | 467.03%983K |
| Net common stock issuance | -75.25%3.32M | 49.21%13.42M | --8.99M | --4.94M | --845K | ---- | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --2M | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---206K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -13.92%14.86M | 220.95%17.27M | 31.09%5.38M | 47.50%2.57M | -4.17%942K | -53.63%4.1M | -90.87%449K | -72.93%793K | 56.99%1.74M | 467.03%983K |
| Net cash flow | ||||||||||
| Beginning cash position | 2,070.50%6.03M | --278K | --0 | -81.37%185K | -103.53%-93K | -81.40%2.63M | -92.45%181K | -89.01%352K | -87.08%993K | -75.76%2.63M |
| Current changes in cash | -199.70%-5.74M | 1,970.50%5.76M | 110.60%278K | 154.41%358K | 117.35%278K | 77.12%-2.62M | -205.95%-267K | 74.28%-187K | 85.42%-658K | 67.75%-1.6M |
| Effect of exchange rate changes | --0 | --0 | --0 | ---- | ---- | 80.65%-12K | 53.33%-7K | 120.00%16K | -48.48%17K | ---39K |
| End cash Position | -95.11%295K | 2,070.50%6.03M | --278K | 54.26%543K | -81.37%185K | --0 | -103.53%-93K | -92.45%181K | -89.01%352K | -83.16%993K |
| Free cash flow | -71.04%-20.6M | -133.68%-12.04M | 23.37%-5.15M | 7.05%-2.08M | 72.40%-665K | 62.26%-6.73M | 74.56%-689K | 73.24%-910K | 54.97%-2.24M | 23.92%-2.41M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg